Could a dye-and-radiation combo spare ovarian cancer patients from extensive lymph node removal?

NCT ID NCT05937620

Recruiting now Diagnosis Sponsor: Fundacion Clinic per a la Recerca Biomédica Source: ClinicalTrials.gov ↗

First seen Feb 14, 2026 · Last updated Jun 14, 2026 · Updated 21 times

Summary

This study tests whether a combination of a radioactive tracer and a green dye can accurately identify the first lymph nodes that ovarian cancer may spread to. About 62 women with early-stage ovarian cancer will receive both tracers before surgery. If successful, this approach could allow surgeons to remove only the key lymph nodes instead of many, reducing side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVARIAN EPITHELIAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Laura Burunat
RECRUITING

Barcelona, Catalonia, 08036, Spain

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

Carcinoma, Ovarian Epithelial ovarian carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OVARIAN EPITHELIAL CANCER